Detection of Herpes Simplex Virus Type 1 in Patients Affected by Conjunctivitis http://www.doi.org/10.26538/tjnpr/v6i11.5
Article Sidebar
Main Article Content
Abstract
Herpes simplex virus (HSV) is a common human pathogen that causes severe infections in newborns and immunocompromised patients. Conjunctivitis or corneal epithelial keratitis is caused by HSV type 1 all over the world and at all times of the year. The present study was aimed at detecting HSV in patients suffering from conjunctivitis. One hundred and ten (110) clinical samples (90 patients and 20 controls, both males and females) of eye conjunctiva swabs were collected from patients of different ages. The samples were analyzed using qPCR and ELISA techniques. The qPCR results revealed that HSV was present in 47 (52.2%) of the 90 patients who were infected. Of these patients, 25 (48.0%) were males and 22 (57.8%) were females, indicating that females are more susceptible to infection. According to the results by age group, patients over 50 years old had a higher rate (81.8%), making young adults more
susceptible to infection. The prevalence of HSV-positive results by ELISA was observed in 29 (32.3%) individuals, including 16 (30.7%) males and 13 (34.2%) females, indicating that females are more susceptible to infection. Adults over the age of 50 (54.5%) are more
susceptible to infection, according to the age group’s HSV-positive outcomes. HSV type 1 infection is highly prevalent among Iraqi conjunctivitis patients, with a statistically significant difference when compared to controls, based on the two techniques. The findings of this study indicate that qPCR is more accurate and reliable than the ELISA technique for detecting HSV type 1.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Puri LR, Shrestha GB, Shah DN, Chaudhary M, Thakar A. Ocular manifestations in herpes zoster ophthalmicus. Nepalese J Ophthalmol. 2011; 3(2):165-171.
Löwenstein A. Aetiologische Untersuchungen über den fieberhaften Herpes. Munch Med Wochenschr. 1919; 11(66:769- 70.
Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994; 266(5192):1865-1869.
Casto AM, Roychoudhury P, Xie H, Selke S, Perchetti GA, Wofford H, Huang ML, Verjans GM, Gottlieb GS, Wald A, Jerome KR. Large, stable, contemporary interspecies recombination events in circulating human herpes simplex viruses. The J. of Infectious Diseases. 2020; 221(8):1271-1279.
"STD Facts – Genital Herpes". 2017-12-11. Retrieved 30 October 2018.
Chentoufi AA and BenMohamed L. Mucosal herpes immunity and immunopathology to ocular and genital herpes simplex virus infections. Clinical and Developmental Immunology. 2012; 1:2012.
Pinto-Ramírez J, Patiño-Jaramillo NG, García-López AE, GirónLuque F. Herpes simplex virus-1 encephalitis in a kidney transplant patient. Acta Medica Colombiana. 2020; 45(2):36-40.
Richards A and Guzman-Cottrill JA. Conjunctivitis. Pediatrics in review. 2010; 31(5):196-208.
Azher TN, Yin XT, Tajfirouz D, Huang AJ, Stuart PM. Herpes simplex keratitis: challenges in diagnosis and clinical management. Clinical Ophthalmology (Auckland, NZ). 2017; 11(1):185-191.
Conde-Glez C, Lazcano-Ponce E, Rojas R, DeAntonio R, Romano-Mazzotti L, Cervantes Y, Ortega-Barria E. Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico. Vaccine. 2013; 31(44):5067-5074.
Lee DH, Zuckerman RA. AST Infectious Diseases Community of Practice. Herpes simplex virus infections in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin transplant. 2019; 33(9):e13526.
Khadr L, Harfouche M, Omori R, Schwarzer G, Chemaitelly H, Abu-Raddad LJ. The epidemiology of herpes simplex virus type 1 in Asia: systematic review, meta-analyses, and metaregressions. Clin Infect Dis. 2019; 68(5):757-72.
Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY. Global data on blindness. Bulletin of the world health organization. 1995; 73(1):115-121.
Sharma S. Diagnosis of infectious diseases of the eye. Eye. 2012; 26(2):177-184.
Yousuf W, Ibrahim H, Harfouche M, Hijleh FA, Abu-Raddad L. Herpes simplex virus type 1 in Europe: systematic review, metaanalyses and meta-regressions. BMJ global health. 2020; 5(7):e002388.
Isacsohn M, Smetana Z, Rones ZZ, Raveh D, Diamant Y, Samueloff A, Shaya M, Mendelson E, Slater P, Rudenski B, On EB. A sero-epidemiological study of herpes virus type 1 and 2 infection in Israel. J clin virol. 2002; 24(1-2):85-92.
Vyse AJ, Gay NJ, Slomka MJ, Gopal R, Gibbs T, MorganCapner P, Brown DW. The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sexu transmit infect. 2000; 76(3):183-187.
Gibson JJ, Hornung CA, Alexander GR, Lee FK, Potts WA, Nahmias AJ. A cross-sectional study of herpes simplex virus types 1 and 2 in college students: occurrence and determinants of infection. J Infect Dis. 1990; 162(2):306-312.
Xu F, Schillinger JA, Sternberg MR, Johnson RE, Lee FK, Nahmias AJ, Markowitz LE. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988–1994. J Infect Dis. 2002; 185(8):1019-1024.
Becker Y. HSV-1 brain infection by the olfactory nerve route and virus latency and reactivation may cause learning and behavioral deficiencies and violence in children and adults: a point of view. Virus genes. 1995; 10(3):217-226.
Becker TM, Magder L, Harrison HR, Stewart JA, Humphrey DD, Hauler J, Nahmias AJ. The epidemiology of infection with the human herpesviruses in Navajo children. Am j epidemiol. 1988; 127(5):1071-1078.
Wutzler P, Doerr HW, Färber I, Eichhorn U, Helbig B, Sauerbrei A, Brandstädt A, Rabenau HF. Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations— relevance for the incidence of genital herpes. J Med Virol. 2000; 61(2):201-207.
Ahmed AA, Khaleel KJ, Fadhel AA, Al-Rubaii BAL. Chronic Myeloid Leukemia: A retrospective study of clinical and pathological features. Bionatura. 2022; 7(3):41. DOI. 10.21931/RB/2022.07.03.41.
Ali SM, Lafta BA, Al-Shammary AM, Salih HS. In vivo oncolytic activity of non-virulent newcastle disease virus Iraqi strain against mouse mammary adenocarcinoma. AIP Conference Proceedings, 2021; 2372, 030010.
Awadh HA, Hammed ZN, Hamzah SS, Saleh TH, Al-Rubaii BAL. Molecular identification of intracellular survival related Brucella melitensis virulence factors. Biomedicine (India), 2022; 42(4):761–765.
Fakhry SS, Hammed ZN, Bakir WAE, ALRubaii BAL. Identification of methicillin-resistant strains of Staphylococcus aureus isolated from humans and food sources by use mecA 1 and mecA 2 genes in Pulsed-field gel electrophoresis technique. Bionatura. .2022; 7(2):44. DOI. 10.21931/RB/2022.07.02.44.
Ali M and Al-Rubaii B. Study of the Effects of Audible Sounds and Magnetic Fields on Staphylococcus aureus Methicillin Resistance and mecA Gene Expression. Trop J Nat Prod Res. 2021; 5(5):825-830.
Hashim ST, Fakhry SS, Rasoul LM, Saleh TH, Alrubaii BAL. Genotyping toxins of Clostridium perfringens strains of rabbit and other animal origins. Trop J Nat Prod Res. 2021; 5(4): 613– 616.
Kadhim AL-Imam MJ,AL-Rubaii BAL. The influence of some amino acids,vitamins and anti-inflammatory drugs on activity of chondroitinase produced by Proteus vulgaris caused urinary tract infection. Iraqi J Sci. 2016; 57 (4A):2412-2421.
Jiad AL, Ismael MK, Salih TA, Malik SN, Al-Rubaii BAL. Genotyping and evaluation of interleukin-10 and soluble HLA-G in abortion due to toxoplasmosis and HSV-2 infections. Ann Parasitol. 2022; 68(2):385–390.
Jiad AL, Ismael MK, Muhsin SS , ALRubaii BAL .ND2 Gene Sequencing of Sub fertile Patients Recovered from COVID-19 in Association with Toxoplasmosis. Bionatura. 2022; 7(3):45. http://dx.doi.org/10.21931/RB/2022.07.03.45.
Rasoul LM, Nsaif MM, Al-Tameemi MT, Al-Rubaii BAL. Estimation of primer efficiency in multiplex PCR for detecting SARS-Cov-2 variants. . Bionatura. 2022; 7(3): 48. http://dx.doi.org/10.21931/RB/2022.07.03.49.